In 2016 - Dr. Willy Davila* began his on-going Non-Comparative Study to Assess the Use of Pixel CO

2 Laser

System (FemiLift) in the Treatment of Vulvovaginal Atrophy (VVA) in Postmenopausal Female Subjects.**

* https://clinicaltrials.gov/ct2/show/NCT02747641?term=femilift&rank=1. ** G. Willy Davila, MD, Chairman, Department of Gynecology, Head of the Section of Urogynecology and Reconstructive Pelvic Surgery at Cleveland Clinic Florida, USA

FE02221701 Rev. A

SUIStress UrinaryIncontinence

GSMGenito Urinary

Syndrome of Menopause

30%of Women Suffer

From SUI Problems

50%of menopausal women suffer

from GSM problems

Number of Post Menopausal Women in the World

The North American Menopause Society, Clinical Care Recommendations

1998 2017 2018 2019 2020 2021 2022 2023 2024 2025

Over

30,000 TREATMENTS

PERFORMED worldwide

100%SATISFACTION

REPORTEDon websites like realself.com

VAGINAL DRYNESS/ATROPHY

1/3 Women over the age of 40 suffer from

477,000,000 1.1BILLION

30%

50%

Did you Know?

1/2 women over the age of 65 will have a

within their lifetime.

According to previous studies published in Neurourology and Urodynamics, more than 15 million women are suffering from a

variety of feminine health conditions...

Associated costs for treating pelvic health concerns are soaring as the populations ages—from an estimated $66 billion in 2007 to a projected cost of $83 billion in 2020**Tara Bahrampour, December 22, 2015 Washington Post2007 - 2020

$ $$

Femilift is changing women’s lives everywhere and is endorsed by physicians around the world

A Fractional CO2 10,600nm

True Multiplatform

capabilitiesImproves

Feminine Health Conditions

Facial Skin Resurfacing

Cutting and incision capability with multiple hand pieces and applicators

Uses a single use Hygienic sheath with

no limit on stacking

Easy to operateChoose the best fluence for the right patient

Next Generation Optical Beam

Splitting Technology

Vaginal Mucosa Results